Maryland has a robust pharmaceutical manufacturing sector that focuses on research and production of drugs and biotechnological products. This industry features companies from large corporations to innovative start-ups, all dedicated to enhancing healthcare. They specialize in various areas including drug replication, biotechnology, and genetic therapy. With a strong emphasis on advanced tech and compliance, these companies are gearing up to meet FDA regulations while innovating rapidly. Future trends suggest growth in biologics and personalized medicine, reinforcing Maryland's position as a pivotal hub for pharmaceutical advancements and fostering collaborations with academia and healthcare institutions.

The companies listed here vary in size and expertise, ranging from established firms like Pii, A Jabil Company, to nimble startups such as VERALOX Therapeutics. Headquarters are spread across Maryland cities such as Rockville, Gaithersburg, and Salisbury. Founded as early as 1957 and as recently as 2019, each company offers specialized services from vaccine development to generic medicine. This mix not only showcases the region’s talent pool but also its adaptability in an ever-evolving industry landscape, anticipating the need for innovative solutions to pressing health challenges.

Continue reading to discover Maryland's top pharmaceutical manufacturing companies.

Top 19 Pharmaceutical Manufacturing Companies in Maryland

1. Pii, A Jabil Company

• Website: pharm-int.com
• Ownership type: Corporate
• Headquarters: Cockeysville, Maryland, United States (USA)
• Employee distribution: United States (USA) 99%
• Latest funding: February 2025
• Founded year: 1994
• Headcount: 201-500
• LinkedIn: pharmaceutics-international

Pii, A Jabil Company, founded in 1994, operates as a contract development and manufacturing organization (CDMO) based in Cockeysville, Maryland. The company has grown significantly, employing around 362 individuals, including a robust team of scientists and support staff. Pii specializes in providing a range of pharmaceutical and biotechnology services, including formulation and process development, analytical services, and quality assurance. Their facilities are equipped to handle various drug forms, including highly potent active pharmaceutical ingredients (HPAPIs) and biologics. Pii's commitment to quality and regulatory compliance is evident in their state-of-the-art manufacturing rooms and containment suites designed for high-potency compounds. They focus on customizing solutions to meet the specific needs of their clients, ensuring efficient drug development and manufacturing processes. Pii's expertise in areas such as aseptic fill-finish and oral drug development further solidifies their role in the pharmaceutical manufacturing landscape.

2. TopAlliance Biosciences Inc

• Website: topalliancebio.com
• Ownership type: Private Equity
• Headquarters: Rockville, Maryland, United States (USA)
• Employee distribution: United States (USA) 78%, Singapore 13%, China 9%
• Latest funding: January 2014
• Founded year: 2013
• Headcount: 11-50
• LinkedIn: topalliance-biosciences-inc

TopAlliance Biosciences Inc, founded in 2013 and based in Rockville, Maryland, is a biopharmaceutical company dedicated to the discovery and development of innovative drugs, with a strong emphasis on oncology. The company operates through advanced research and development processes and has established manufacturing capabilities to support its drug candidates. Their flagship therapy, LOQTORZI™ (also known as Toripalimab), is an anti-PD-1 monoclonal antibody that has shown promising clinical results and has been approved by the FDA for the treatment of recurrent or metastatic nasopharyngeal carcinoma. TopAlliance is part of a global network, with operations in the United States, Singapore, and China, and is backed by its parent company, Shanghai Junshi Biosciences, which has a notable history in the biopharmaceutical industry. The company is committed to advancing therapies that address unmet medical needs, particularly in cancer treatment, and has a robust pipeline of drug candidates.

3. Leadiant Biosciences, inc.

• Website: leadiant.com
• Ownership type: Private
• Headquarters: Gaithersburg, Maryland, United States (USA)
• Employee distribution: United States (USA) 79%, Italy 21%
• Founded year: 1957
• Headcount: 51-200
• LinkedIn: sigma-tau-pharmaceuticals-inc-

Leadiant Biosciences, Inc., based in Gaithersburg, Maryland, is a private pharmaceutical company founded in 1957. The company is dedicated to the research, development, and distribution of therapies aimed at treating rare diseases. With a workforce of approximately 53 employees, Leadiant focuses on creating innovative solutions that enhance the quality of life for patients facing unique health challenges. Their product offerings include Abelcet® (amphotericin B lipid complex injection), Carnitor® (levocarnitine), Cystaran® (cysteamine ophthalmic solution), and Matulane® (procarbazine hydrochloride). Leadiant's commitment to patient care is evident in their efforts to provide resources and support for patients and caregivers, ensuring that their voices are heard in the drug development process. The company operates primarily in the United States, with a notable presence in Italy, reflecting its international reach in addressing rare diseases.

4. Jubilant Cadista Pharmaceuticals

• Website: cadista.com
• Ownership type: Corporate
• Headquarters: Salisbury, Maryland, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: December 2014
• Founded year: 2005
• Headcount: 201-500
• LinkedIn: jubilantcadista-pharmaceuticals

Jubilant Cadista Pharmaceuticals Inc. is a pharmaceutical company based in Salisbury, Maryland, established in 2005. The company focuses on the development, manufacture, and distribution of generic medications, aiming to provide high-quality and affordable pharmaceuticals to healthcare providers and pharmacies. With a workforce of approximately 138 employees, Jubilant Cadista emphasizes a commitment to quality and customer service throughout its operations. They cater to various therapeutic categories, ensuring that patients have access to essential medications. The company operates under the umbrella of Jubilant Generics Limited, which serves customers globally, enhancing their reach and impact in the pharmaceutical market. Their manufacturing facilities are designed to support the production of solid dosage formulations, contributing significantly to the supply of generics in the U.S. market and beyond.

5. WES Pharma Inc

• Website: wespharma.com
• Ownership type: Private
• Headquarters: Westminster, Maryland, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2012
• Headcount: 11-50
• LinkedIn: wes-pharma-inc

WES Pharma Inc, founded in 2012 and based in Westminster, Maryland, is a private pharmaceutical company that specializes in the development and manufacturing of challenging specialty generics. The company operates from a 32,000 square foot facility equipped with state-of-the-art technology, allowing them to produce a range of products including tablets, capsules, and liquid dosage forms. WES Pharma's team of skilled scientists employs advanced techniques in product development, ensuring that their offerings meet stringent FDA standards. They focus on complex formulations that often face technical and scientific hurdles, aiming to provide cost-effective solutions for healthcare providers and patients. Their business model includes nurturing the entire product lifecycle, from initial research and development through to FDA approval and manufacturing. WES Pharma collaborates with other pharmaceutical companies to enhance their development and marketing capabilities, further solidifying their role in the pharmaceutical industry.

6. On Demand Pharmaceuticals Inc

• Website: ondemandpharma.com
• Ownership type: Private
• Headquarters: Rockville, Maryland, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2016
• Headcount: 51-200
• LinkedIn: ondemandpharma

On Demand Pharmaceuticals Inc, founded in 2016 and based in Rockville, Maryland, is a private pharmaceutical company dedicated to enhancing access to affordable medications. The company specializes in agile medicine-making capabilities, offering innovative solutions like subscription services and point-of-care delivery systems. Their primary focus is on providing healthcare professionals and organizations with efficient medication solutions. On Demand Pharmaceuticals is actively involved in addressing healthcare challenges, such as drug shortages, by producing medications on-site in partnership with healthcare providers. Their mission is to revolutionize the pharmaceutical sector by creating transparent and efficient supply chains, ensuring that high-quality medications are accessible to all patients, regardless of their location.

7. BioFactura, Inc.

• Website: biofactura.com
• Ownership type: Corporate
• Headquarters: Frederick, Maryland, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Other (Grant), $1.0M, July 2020
• Founded year: 2003
• Headcount: 11-50
• LinkedIn: biofactura-inc-

BioFactura, Inc., founded in 2003 and based in Frederick, Maryland, is a biopharmaceutical company dedicated to developing and manufacturing high-value biosimilars and biodefense medical countermeasures. The company aims to meet unmet medical needs through innovative drug development, particularly focusing on therapeutics for smallpox and Marburg virus. BioFactura utilizes its proprietary StableFast Biomanufacturing Platform, which allows for rapid and cost-effective production of biologics. The company has received significant funding, including a $1 million grant in 2020, to support its initiatives. BioFactura's clientele includes government agencies and healthcare organizations, highlighting its role in providing effective treatments against biological threats. With a team experienced in bioprocess development and manufacturing, BioFactura is positioned to advance life-saving medicines from research to market.

8. Innoforce Pharmaceuticals

• Website: innoforcepharma.com
• Ownership type: Venture Capital
• Headquarters: Sykesville, Maryland, United States (USA)
• Employee distribution: China 91%, United States (USA) 9%
• Latest funding: Series A, $58.8M, December 2021
• Founded year: 2018
• Headcount: 201-500
• LinkedIn: innoforcepharma

Innoforce Pharmaceuticals, founded in 2018 and based in Sykesville, Maryland, is a biotechnology firm that provides contract development and manufacturing organization (CDMO) services specifically for advanced therapy medicinal products (ATMPs). The company focuses on the production of plasmid DNA, RNA, and viral vectors, catering to the needs of biopharmaceutical companies and research institutions. With a commitment to ensuring the stability and efficacy of these products for both clinical and commercial applications, Innoforce plays a crucial role in the development of innovative therapies. The company has a significant presence in China, where 91% of its employees are located, and has recently secured $58 million in Series A funding to enhance its capabilities. This funding supports their mission to accelerate the innovation and global supply of advanced therapies, making them a relevant player in the pharmaceutical manufacturing sector.

9. Integrated BioTherapeutics, Inc.

• Website: integratedbiotherapeutics.com
• Ownership type: Private
• Headquarters: Rockville, Maryland, United States (USA)
• Latest funding: $1.0M, May 2023
• Founded year: 2005
• Headcount: 11-50
• LinkedIn: integrated-biotherapeutics-inc.

Integrated BioTherapeutics, Inc. (IBT), founded in 2005 and based in Rockville, Maryland, is a biotechnology firm dedicated to the development of vaccines and antibody therapeutics aimed at combating infectious diseases. The company specializes in creating innovative solutions to address emerging viral infections and antibiotic-resistant bacterial threats. Their pipeline includes promising candidates for the prevention and treatment of various infections, including those caused by Staphylococcus aureus, Ebola, and Marburg viruses. IBT has established collaborations with government agencies and academic institutions, enhancing their research capabilities and product development. Notably, their S. aureus vaccine is expected to enter clinical trials in 2024, showcasing their commitment to advancing public health solutions. In May 2023, IBT secured $1 million in funding, reflecting continued investor confidence in their mission and projects.

10. Nobelpharma America, LLC

• Website: nobelpharma-us.com
• Ownership type: Private
• Headquarters: Bethesda, Maryland, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2019
• Headcount: 11-50
• LinkedIn: nobelpharma

Nobelpharma America, LLC, established in 2019 and based in Bethesda, Maryland, is a subsidiary of a Japanese pharmaceutical company. The firm is dedicated to developing critical but neglected drugs and medical devices aimed at rare and underserved medical conditions. With a workforce of 11-50 employees, Nobelpharma America operates with a clear mission: to fill treatment gaps for diseases that often lack attention due to their low patient populations. The company collaborates with global experts to expedite the development and delivery of essential medicines. Their pipeline includes products that have received approval in Japan, although they are still in the investigational phase in the U.S. market. Nobelpharma America emphasizes a patient-first approach, striving to bring innovative solutions to healthcare providers and patients alike.

11. Immunomic Therapeutics, Inc.

• Website: immunomix.com
• Ownership type: Venture Capital
• Headquarters: Rockville, Maryland, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: $3.0M, April 2024
• Founded year: 2005
• Headcount: 11-50
• LinkedIn: immunomic-therapeutics-inc-

Immunomic Therapeutics, Inc. is a clinical-stage biotechnology company based in Rockville, Maryland. Founded in 2005, the company specializes in the development of innovative immunotherapies and vaccines, primarily targeting oncology and other therapeutic areas. Their proprietary technology platform, UNITE® (UNiversal Intracellular Targeted Expression), is designed to utilize the body's natural biochemistry to generate broad immune responses. Immunomic Therapeutics is actively engaged in clinical trials, with ongoing studies for treatments targeting glioblastoma multiforme and Merkel cell carcinoma. The company collaborates with notable research institutions, including the University of Florida and Dana Farber Cancer Institute, to advance their clinical programs. Recently, they secured $3 million in funding, indicating continued investor interest in their innovative approaches to cancer treatment.

12. Rise Therapeutics

• Website: risetherapeutics.com
• Ownership type: Venture Capital
• Headquarters: Rockville, Maryland, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Other (Grant), October 2024
• Founded year: 2017
• Headcount: 1-10
• LinkedIn: rise-therapeutics

Rise Therapeutics, founded in 2017 and based in Rockville, Maryland, is a biotechnology company dedicated to developing targeted immunological-based biologics. The company specializes in creating innovative oral immunotherapeutics aimed at treating chronic diseases such as autoimmunity, cancer, and infections. Rise Therapeutics leverages cutting-edge research in synthetic biology and microbiome science to advance its drug development efforts. They have established clinical GMP manufacturing capabilities, allowing them to translate laboratory discoveries into viable products efficiently. Recently, the company received FDA clearance for a Phase 1 clinical study of its novel oral immunotherapy for rheumatoid arthritis, showcasing its active role in the pharmaceutical industry. With a focus on collaboration, Rise Therapeutics seeks partnerships with academic and pharmaceutical entities to further its mission of developing life-changing therapies.

13. VERALOX Therapeutics

• Website: veralox.com
• Ownership type: Venture Capital
• Headquarters: Frederick, Maryland, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: $24.0M, June 2023
• Founded year: 2018
• Headcount: 1-10
• LinkedIn: veralox-therapeutics

VERALOX Therapeutics, founded in 2018 and based in Frederick, Maryland, is a biotechnology company dedicated to creating innovative therapies for life-threatening immuno-inflammatory diseases. The company is currently developing its lead product, VLX-1005, which targets heparin-induced thrombocytopenia (HIT). This first-in-class small molecule inhibitor has shown promise in preclinical studies, demonstrating the potential to halt immune-driven platelet activation and thrombosis. VERALOX has received significant recognition for its work, including orphan drug designations from both the FDA and EMA, highlighting its focus on addressing critical medical needs. With a small team of around 18 employees, the company has secured $24 million in funding as of June 2023, which supports its ongoing research and development efforts in the pharmaceutical industry.

14. OncoC4, Inc.

• Website: oncoc4.com
• Ownership type: Private
• Headquarters: Rockville, Maryland, United States (USA)
• Employee distribution: United States (USA) 97%, Australia 3%
• Founded year: 2020
• Headcount: 51-200
• LinkedIn: oncoc4

OncoC4, Inc., founded in 2020 and based in Rockville, Maryland, is a private biopharmaceutical company dedicated to developing innovative therapies for cancer treatment. The company specializes in targeting immune checkpoints, which are crucial in regulating the immune system's response to cancer. OncoC4's pipeline includes several promising programs, such as their CTLA-4 antibody therapy, gotistobart, which is currently in clinical trials for various advanced cancers. Their scientific approach is rooted in extensive research conducted by a team of experienced immunologists and business strategists. OncoC4 aims to provide patients with more effective and safer treatment options for difficult-to-treat cancers, reflecting their commitment to advancing cancer care.

15. Salubris Biotherapeutics

• Website: salubrisbio.com
• Ownership type: Corporate
• Headquarters: Gaithersburg, Maryland, United States (USA)
• Employee distribution: United States (USA) 83%, Vietnam 9%, China 9%
• Latest funding: Series A, $35.0M, April 2024
• Founded year: 2016
• Headcount: 11-50
• LinkedIn: salubris-biotherapeutics

Salubris Biotherapeutics, Inc. is a biotechnology firm based in Gaithersburg, Maryland, established in 2016. The company specializes in the development of innovative biologics aimed at treating complicated diseases, with a strong focus on cardiovascular conditions and oncology. Salubris is recognized for its pioneering work, being the first to bring a bispecific antibody into clinical trials for cardiovascular indications. Their product pipeline includes promising candidates like JK06, JK07, and JK08, which target critical health challenges and aim to improve patient outcomes. Salubris has a dedicated team of industry experts and is actively involved in clinical trials to advance their therapeutic offerings. The company has recently secured $35 million in Series A funding, which underscores its commitment to research and development in the pharmaceutical sector.

16. Sanaria Inc.

• Website: sanaria.com
• Ownership type: Private
• Headquarters: Rockville, Maryland, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2003
• Headcount: 11-50
• LinkedIn: sanaria-inc

Sanaria Inc. is a biotechnology firm based in Rockville, Maryland, established in 2003. The company specializes in the development of vaccines aimed at preventing malaria, a disease that poses a significant threat to global health. Sanaria's innovative vaccines are based on the use of live attenuated sporozoites from the malaria parasite _Plasmodium falciparum_. Their manufacturing facility is unique, designed specifically for the production of malaria vaccine candidates, ensuring high-quality output in a controlled environment. Sanaria actively engages in clinical trials across various regions, including Africa, Europe, and the United States, to evaluate the efficacy and safety of its vaccine candidates. The company also provides research reagents and services to support the broader biomedical community in malaria research and vaccine development.

17. Itaan Pharma

• Website: itaanpharma.com
• Ownership type: Private
• Headquarters: Frederick, Maryland, United States (USA)
• Employee distribution: India 100%
• Founded year: 2020
• Headcount: 51-200
• LinkedIn: itaan-pharma

Itaan Pharma, founded in 2020 and based in Frederick, Maryland, is a private pharmaceutical manufacturer that specializes in injectable formulations. The company is dedicated to producing high-quality glass and polypropylene vials tailored for the healthcare industry. With a workforce of approximately 78 employees, Itaan Pharma emphasizes quality and compliance with regulatory standards, ensuring that healthcare providers receive dependable products for patient care. Their manufacturing capabilities include aseptic filling, lyophilization, and terminal sterilization, all conducted in a facility designed to meet rigorous cleanroom and GMP standards. The company operates with a patient-centric approach, focusing on integrity, trust, accountability, adaptability, and novelty in their operations. Although Itaan Pharma has not reported any funding, their commitment to innovation and quality positions them as a significant player in the injectable medication market.

18. Longhorn Vaccines and Diagnostics, LLC

• Website: lhnvd.com
• Ownership type: Family Owned
• Headquarters: Bethesda, Maryland, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2007
• Headcount: 11-50
• LinkedIn: longhorn-vaccines-and-diagnostics-llc

Longhorn Vaccines and Diagnostics, LLC, based in Bethesda, Maryland, is a family-owned healthcare company founded in 2007. The firm focuses on the development of vaccines and diagnostic tools aimed at combating infectious diseases. Their flagship product, PrimeStore MTM, is a patented molecular transport medium that has been crucial in the safe collection and transport of samples, particularly during the COVID-19 pandemic. Longhorn is also advancing the LHNVD-105, a universal influenza vaccine designed to provide broad protection against various strains. The company collaborates with government agencies and healthcare organizations, ensuring that their innovative solutions meet the needs of public health. Their work spans critical areas such as influenza, coronavirus, and antibiotic resistance, positioning them as a relevant player in the pharmaceutical manufacturing industry.

19. Georgiamune Inc.

• Website: georgiamune.com
• Ownership type: Venture Capital
• Headquarters: Gaithersburg, Maryland, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Series A, $75.0M, August 2023
• Founded year: 2014
• Headcount: 11-50
• LinkedIn: georgiamune

Georgiamune Inc., founded in 2014 and based in Gaithersburg, Maryland, is a biopharmaceutical company dedicated to the development of innovative immunotherapeutics aimed at treating cancer and autoimmune diseases. The company specializes in reprogramming immune responses through a pipeline of first-in-class drugs designed to target significant unmet medical needs. Their portfolio includes several promising candidates, such as GIM-122, a dual-functioning antibody, and GIM-531, a Treg inhibitor, among others. Georgiamune's customers include healthcare providers and pharmaceutical companies seeking advanced treatment options. Recently, the company secured $75 million in Series A funding, which underscores its potential and the interest it has garnered in the biopharmaceutical sector. With a team of experienced scientists and clinicians, Georgiamune is positioned to make meaningful contributions to the field of immunotherapy.

Pharmaceutical Manufacturing Insights: Key Companies in Maryland

Want to Find More Pharmaceutical Manufacturing Companies?

With Inven you'll also get to know the company's:

• Detailed Ownership: Who owns the company? Is it a public or private company? What is the ownership structure?
• Contact data: Who are the founders and CEO's? What are their emails and phone numbers?
• Financials: How do these companies perform financially? What are their revenues and profit margins?

...and a lot more!